Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Cancer Immunology, Immunotherapy : CII|June 9, 2023
Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancerColt A Egelston, Weihua Guo, Susan E Yost, et al.
European Journal of Cancer (Oxford, England : 1990)|July 4, 2021
Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancerYuan Yuan, Jin Sun Lee, Susan E Yost, et al.
Antioxidants (Basel, Switzerland)|December 30, 2025
Correction: Senguttuvan et al. The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate. Antioxidants 2025, 14, 345Rosemary N Senguttuvan, Hyejin Cho, Xiwei Wu, et al.
Antioxidants (Basel, Switzerland)|April 14, 2025
The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol AcetateRosemary N Senguttuvan, Hyejin Cho, Xiwei Wu, et al.
The Oncologist|November 3, 2020
A Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor-Positive Metastatic Triple-Negative Breast CancerYuan Yuan, Jin Sun Lee, Susan E Yost, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2018
Identification of Tissue-Specific DNA Methylation Signatures for Thyroid Nodule DiagnosticsJohn H Yim, Audrey H Choi, Arthur X Li, et al.
The Oncologist|October 24, 2020
Phase II Trial of Neoadjuvant Carboplatin and Nab-Paclitaxel in Patients with Triple-Negative Breast CancerYuan Yuan, Jin Sun Lee, Susan E Yost, et al.
Cancer Research|May 5, 2023
Profiling the Somatic Mutational Landscape of Breast Tumors from Hispanic/Latina Women Reveals Conserved and Unique CharacteristicsYuan Chun Ding, Hanbing Song, Aaron W Adamson, et al.
JCO Precision Oncology|March 31, 2022
Hyperthermic Intraperitoneal Chemotherapy-Induced Molecular Changes in Humans Validate Preclinical Data in Ovarian CancerThanh H Dellinger, Ernest S Han, Mustafa Raoof, et al.
Cancer Cell|August 31, 2023
Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric studySophia J Wagner, Daniel Reisenbüchler, Nicholas P West, et al.
Pageof 6